Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hikma Pharmaceuticals PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
HKMPY
Over the counter
2834
www.hikma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hikma Pharmaceuticals PLC
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg
- Jan 14th, 2025 12:41 pm
Is Hikma Pharmaceuticals PLC (HIK.L) Among the U.K. Dividend Aristocrats for 2024?
- Dec 29th, 2024 9:27 am
Hikma Pharmaceuticals PLC's (LON:HIK) Stock Is Going Strong: Have Financials A Role To Play?
- Dec 20th, 2024 9:40 am
Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 95% Above Its Share Price
- Nov 23rd, 2024 8:59 am
Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
- Nov 1st, 2024 4:24 pm
With 55% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backing
- Sep 25th, 2024 5:33 am
Hikma Pharmaceuticals (LON:HIK) shareholders have endured a 17% loss from investing in the stock three years ago
- Sep 4th, 2024 12:59 pm
Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day
- Aug 20th, 2024 4:15 pm
KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months
- Aug 15th, 2024 7:18 pm
We Think Hikma Pharmaceuticals' (LON:HIK) Robust Earnings Are Conservative
- Aug 15th, 2024 5:58 am
Hikma Pharmaceuticals (HKMPF) Upgraded to Buy: Here's What You Should Know
- Aug 12th, 2024 4:00 pm
Hikma Pharmaceuticals PLC Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next
- Aug 11th, 2024 9:08 am
Hikma Pharmaceuticals First Half 2024 Earnings: Beats Expectations
- Aug 10th, 2024 9:02 am
Hikma Pharmaceuticals shares surge on upbeat guidance
- Aug 8th, 2024 9:20 am
Does The Market Have A Low Tolerance For Hikma Pharmaceuticals PLC's (LON:HIK) Mixed Fundamentals?
- Jul 12th, 2024 7:27 am
An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 35% Undervalued
- Jun 3rd, 2024 6:42 am
With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns
- Apr 15th, 2024 6:20 am
Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week
- Mar 18th, 2024 11:29 am
Merck's Bridion faces generic threat from drugmaker Hikma
- Feb 26th, 2024 10:50 pm
Hikma hosts White House Drug Policy Director Dr. Rahul Gupta at its Columbus, Ohio manufacturing facility
- Feb 21st, 2024 6:20 pm
Scroll